QT
COGT icon

Quantbot Technologies’s Cogent Biosciences COGT Stock Holding History

Quantbot Technologies’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.62K Sell
42
-5,373
-99% -$198K ﹤0.01% 1616
2025
Q4 		$192K Sell
5,415
-5,752
-52% -$162K 0.01% 1250
2025
Q3 		$160K Sell
11,167
-4,350
-28% -$51.5K ﹤0.01% 1358
2025
Q2 		$111K Sell
15,517
-5,533
-26% -$30.7K ﹤0.01% 1384
2025
Q1 		$126K Sell
21,050
-603
-3% -$4.73K ﹤0.01% 1208
2024
Q4 		$169K Buy
+21,653
New +$216K 0.01% 1086
2023
Q1 		– Sell
-2,100
Closed -$24.3K – 1619
2022
Q4 		$24.3K Sell
2,100
-19,800
-90% -$245K ﹤0.01% 1417
2022
Q3 		$326K Buy
21,900
+15,900
+265% +$218K 0.02% 725
2022
Q2 		$54K Buy
6,000
+3,600
+150% +$24.6K 0.01% 1289
2022
Q1 		$17K Sell
2,400
-400
-14% -$2.79K ﹤0.01% 1388
2021
Q4 		$24K Buy
+2,800
New +$24.3K ﹤0.01% 1192

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Quantbot Technologies's COGT Position: Q1 2026 in Review

Quantbot Technologies reduced its Cogent Biosciences (COGT) stake by 99% in Q1 2026, selling an estimated $198K and leaving 42 shares worth $1.62K. The position accounts for ﹤0.01% of the portfolio, ranked #1616.

Quantbot Technologies first reported a position in COGT in Q4 2021 and has held it in 11 quarters since. The position peaked at $326K in Q3 2022. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Quantbot Technologies held 42 shares of Cogent Biosciences worth $1.62K as of Q1 2026.
  • Quantbot Technologies sold 5,373 Cogent Biosciences shares in Q1 2026, an estimated $198K.
  • Cogent Biosciences made up ﹤0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1616 holding.
  • Quantbot Technologies first reported a position in Cogent Biosciences in Q4 2021 and has held it in 11 quarters since.
  • Quantbot Technologies's Cogent Biosciences position peaked at $326K in Q3 2022.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.